|
Market Closed -
Nasdaq
16:00:00 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 1.690 USD | +4.32% |
|
-5.59% | -15.08% |
Company Valuation: Autolus Therapeutics plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 378.4 | 328.8 | 1,120 | 625.4 | 529.6 | 449.8 | - | - |
| Change | - | -13.12% | 240.67% | -44.17% | -15.31% | -15.07% | - | - |
| Enterprise Value (EV) 1 | 68.11 | -53.95 | 879.8 | 89.99 | 300.3 | 293.8 | 372.4 | 390.2 |
| Change | - | -179.21% | 1,730.86% | -89.77% | 233.7% | -2.17% | 26.77% | 4.78% |
| P/E | -2.63x | -1.21x | -5.37x | -2.73x | -1.84x | -2.08x | -2.42x | -2.87x |
| PBR | 1.51x | 1.1x | 10x | 1.46x | 2.97x | - | - | - |
| PEG | - | 0.1x | 0.2x | 0.1x | -0.1x | 0.1x | 0.2x | 0.2x |
| Capitalization / Revenue | 162x | 51.7x | 660x | 61.8x | 7.03x | 3x | 2.34x | 1.59x |
| EV / Revenue | 29.2x | -8.48x | 518x | 8.89x | 3.98x | 1.96x | 1.94x | 1.38x |
| EV / EBITDA | -0.44x | 0.35x | -5.08x | -0.39x | -1.15x | -1.45x | -2.15x | -4.39x |
| EV / EBIT | -0.42x | 0.33x | -4.9x | -0.37x | -1.11x | -1.48x | -2.3x | -3.08x |
| EV / FCF | -0.54x | 0.44x | -5.62x | -0.39x | -0.99x | -2.49x | -3.49x | -6.02x |
| FCF Yield | -186% | 228% | -17.8% | -254% | -101% | -40.1% | -28.6% | -16.6% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.97 | -1.57 | -1.2 | -0.86 | -1.08 | -0.8116 | -0.6972 | -0.5895 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2.33 | 6.36 | 1.698 | 10.12 | 75.39 | 149.8 | 192.4 | 283.4 |
| EBITDA 1 | -154.2 | -154.3 | -173.1 | -233.7 | -260.7 | -202.3 | -173.6 | -88.93 |
| EBIT 1 | -162.7 | -161.7 | -179.7 | -241.4 | -270.5 | -199.2 | -161.8 | -126.7 |
| Net income 1 | -142.1 | -148.8 | -208.4 | -220.7 | -287.5 | -220.3 | -188.6 | -125.6 |
| Net Debt 1 | -310.3 | -382.8 | -240.3 | -535.4 | -229.3 | -156 | -77.38 | -59.57 |
| Reference price 2 | 5.190 | 1.900 | 6.440 | 2.350 | 1.990 | 1.690 | 1.690 | 1.690 |
| Nbr of stocks (in thousands) | 72,919 | 173,059 | 173,937 | 266,122 | 266,143 | 266,163 | - | - |
| Announcement Date | 3/10/22 | 3/7/23 | 3/14/24 | 3/20/25 | 3/27/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.01x | 1.84x | -1.36x | - | 431M | |
| 33.19x | 12.03x | 25.3x | 0.59% | 1,040B | |
| 36.75x | 6.12x | 17.02x | 2.15% | 599B | |
| 34.92x | 8.07x | 16.64x | 2.53% | 485B | |
| 109.67x | 5.8x | 24.85x | 2.4% | 350B | |
| 19.42x | 4.74x | 11.78x | 2.78% | 345B | |
| 20.05x | 5.27x | 12.97x | 3.02% | 272B | |
| 20.63x | 4.17x | 11.97x | 2.12% | 244B | |
| 26.21x | 6.79x | 12.15x | 2.44% | 223B | |
| -43.22x | 6.62x | 25.76x | 2.23% | 183B | |
| Average | 25.56x | 6.15x | 15.71x | 2.25% | 374.32B | |
| Weighted average by Cap. | 33.93x | 7.73x | 19.03x | 1.93% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AUTL Stock
- Valuation Autolus Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
